Roche

Company:

Roche

1 - Global context of the challenge

The current business model of the majority of pharma companies mostly focus on commercializing products that act primarily at the end of the patient journey (ie: when patients are already diagnosed with a specific disease). Roche has a unique value proposition through its 2 high-tech divisions of Diagnostics and Pharma and would like to understand how Digital Healthcare technologies can shape the future of personalized healthcare and preventive medicine and how these solutions can be integrated within Roche’s value proposition.

2 - Challenge/Opportunity definition

Brief description of the challenge. Could use questions and examples
The current business model of the majority of pharma companies mostly focus on commercializing products that act primarily at the end of the patient journey (ie: when patients are already diagnosed with a specific disease). Roche has a unique value proposition through its 2 high-tech divisions of Diagnostics and Pharma and would like to understand how Digital Healthcare technologies can shape the future of personalized healthcare and preventive medicine and how these solutions can be integrated within Roche’s value proposition.

3 - Why is it important?

Population growth is calculated using a metric called total fertility rate (TFR) -- it measures the average number of children born per woman. For a population to remain stable over time, it must have a TFR of at least 2.1. The Institute for Health Metrics and Evaluation study projects that the global TFR will drop to just 1.66 in 2100. One consequence of this decline in TFR is that there are going to be more elderly than young people. In 2100, for instance, 2.37 billion people will be older than 65, while only 1.7 billion people will be younger than 20. This means increasing global longevity that will drive a need for better healthcare for an ever-aging population where exponential digital healthcare technologies will help our healthcare system meet this challenge. As we are heading towards a future in which all of healthcare is focused on making medicine more personalized, preventive, and accessible, ultimately making you the “CEO of your own health.” Most of what we think of as healthcare today is based on a sick-care model, where our current healthcare system tries to take care of us after we’re sick by treating symptoms. But it doesn’t prevent the root causes of our sickness. As the global population continues to decline and 100 years old becomes the new norm, we will increasingly depend on the convergence of exponential digital healthcare technologies such as AI, sensors, robotics, and 3D printing to help demonetize and democratize both diagnostics and therapies (e.g. surgery, CRISPR and gene therapy) everywhere, all the time. Ultimately, technology will be constantly monitoring our health through wearables, implantables, and consumables that feed data to our personal AI assistant that is watching and optimizing our health. The use of such technologies will allow us to remain productive for many more decades, making retirement optional and not necessary. Now the main challenge is, how and which digital healthcare technologies should Roche develop, partner with or integrate in its current and future value proposition and business model?

4 - What do we want for the solution?

A range of promising disruptive healthcare technologies/solutions to diversify Roche’s existing portfolio and business model for the future.

Submit your pitch now!
arrow&v
Upload additional documents
Max File Size 15MB

( e.g Video or Pitch Deck or 1 page explanation of your solution)

* required questions

© 2020 by BGI, S.A.

Check us here:

Av. Prof. Gama Pinto 3, 1649-003 Lisbon, Portugal

geral@bgi.pt